Macrogenics reported $-52886000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Daiichi Sankyo 4568:JP Y 38893M 8169M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Epizyme EPZM:US $ -65.83M 1.47M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Genmab GEN:DC DK 1171M 749M
Geron GERN:US $ -26.7M 2.88M
Immunogen IMGN:US $ -37.34M 6.6M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Xencor XNCR:US $ -40.19M 92.44M